Four diagnostic markers (LRRTM4, PTPN22, FAM175B, and PROM2) for DCM were identified with high AUC values, indicating their potential regulatory significance in DCM pathogenesis. Here, LRRTM4 is linked to familial dilated cardiomyopathy.